212 related articles for article (PubMed ID: 34678221)
21. Aggregated neutrophil extracellular traps resolve inflammation by proteolysis of cytokines and chemokines and protection from antiproteases.
Hahn J; Schauer C; Czegley C; Kling L; Petru L; Schmid B; Weidner D; Reinwald C; Biermann MHC; Blunder S; Ernst J; Lesner A; Bäuerle T; Palmisano R; Christiansen S; Herrmann M; Bozec A; Gruber R; Schett G; Hoffmann MH
FASEB J; 2019 Jan; 33(1):1401-1414. PubMed ID: 30130433
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological inhibition of cathepsin C (CatC) as a potential approach for cancer therapeutics.
Abideen SA; Khan M; Al-Harbi AI; Ahmad S
J Biomol Struct Dyn; 2023; 41(18):8682-8689. PubMed ID: 36264138
[TBL] [Abstract][Full Text] [Related]
23. Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum.
Dubois AV; Gauthier A; Bréa D; Varaigne F; Diot P; Gauthier F; Attucci S
Am J Respir Cell Mol Biol; 2012 Jul; 47(1):80-6. PubMed ID: 22343221
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of the activation of multiple serine proteases with a cathepsin C inhibitor requires sustained exposure to prevent pro-enzyme processing.
Méthot N; Rubin J; Guay D; Beaulieu C; Ethier D; Reddy TJ; Riendeau D; Percival MD
J Biol Chem; 2007 Jul; 282(29):20836-46. PubMed ID: 17535802
[TBL] [Abstract][Full Text] [Related]
25. Neutrophil serine proteases promote IL-1β generation and injury in necrotizing crescentic glomerulonephritis.
Schreiber A; Pham CT; Hu Y; Schneider W; Luft FC; Kettritz R
J Am Soc Nephrol; 2012 Mar; 23(3):470-82. PubMed ID: 22241891
[TBL] [Abstract][Full Text] [Related]
26. Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis).
Korkmaz B; Lesner A; Letast S; Mahdi YK; Jourdan ML; Dallet-Choisy S; Marchand-Adam S; Kellenberger C; Viaud-Massuard MC; Jenne DE; Gauthier F
Semin Immunopathol; 2013 Jul; 35(4):411-21. PubMed ID: 23385856
[TBL] [Abstract][Full Text] [Related]
27. Tailor-made inflammation: how neutrophil serine proteases modulate the inflammatory response.
Kessenbrock K; Dau T; Jenne DE
J Mol Med (Berl); 2011 Jan; 89(1):23-8. PubMed ID: 20809089
[TBL] [Abstract][Full Text] [Related]
28. In vivo inhibition of serine protease processing requires a high fractional inhibition of cathepsin C.
Méthot N; Guay D; Rubin J; Ethier D; Ortega K; Wong S; Normandin D; Beaulieu C; Reddy TJ; Riendeau D; Percival MD
Mol Pharmacol; 2008 Jun; 73(6):1857-65. PubMed ID: 18326050
[TBL] [Abstract][Full Text] [Related]
29. Neutrophil Proteases Promote Experimental Abdominal Aortic Aneurysm via Extracellular Trap Release and Plasmacytoid Dendritic Cell Activation.
Yan H; Zhou HF; Akk A; Hu Y; Springer LE; Ennis TL; Pham CTN
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1660-1669. PubMed ID: 27283739
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic/Pharmacodynamic Evaluation of the Dipeptidyl Peptidase 1 Inhibitor Brensocatib for Non-cystic Fibrosis Bronchiectasis.
Chalmers JD; Usansky H; Rubino CM; Teper A; Fernandez C; Zou J; Mange KC
Clin Pharmacokinet; 2022 Oct; 61(10):1457-1469. PubMed ID: 35976570
[TBL] [Abstract][Full Text] [Related]
31. Neutrophil serine proteases: mediators of innate immune responses.
Meyer-Hoffert U; Wiedow O
Curr Opin Hematol; 2011 Jan; 18(1):19-24. PubMed ID: 21042214
[TBL] [Abstract][Full Text] [Related]
32. NSP4, an elastase-related protease in human neutrophils with arginine specificity.
Perera NC; Schilling O; Kittel H; Back W; Kremmer E; Jenne DE
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6229-34. PubMed ID: 22474388
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological inhibition of the cysteine protease cathepsin C improves graft function after heart transplantation in rats.
Liu B; Korkmaz B; Kraft P; Mayer T; Sayour AA; Grundl MA; Domain R; Karck M; Szabó G; Korkmaz-Icöz S
J Transl Med; 2023 Nov; 21(1):799. PubMed ID: 37946197
[TBL] [Abstract][Full Text] [Related]
34. Protease inhibitors derived from elafin and SLPI and engineered to have enhanced specificity towards neutrophil serine proteases.
Zani ML; Baranger K; Guyot N; Dallet-Choisy S; Moreau T
Protein Sci; 2009 Mar; 18(3):579-94. PubMed ID: 19241385
[TBL] [Abstract][Full Text] [Related]
35. Identification and Optimization of Novel Cathepsin C Inhibitors Derived from EGFR Inhibitors.
Hou W; Sun H; Ma Y; Liu C; Zhang Z
J Med Chem; 2019 Jun; 62(12):5901-5919. PubMed ID: 31145622
[TBL] [Abstract][Full Text] [Related]
36. An optimized method of extracting and quantifying active Neutrophil serine proteases from human whole blood cells.
Basso J; Zhang J; Lasala D; Rose SJ; Chen KJ; Cipolla D
PLoS One; 2022; 17(8):e0272575. PubMed ID: 36044421
[TBL] [Abstract][Full Text] [Related]
37. Neutrophil serine proteases exert proteolytic activity on endothelial cells.
Jerke U; Hernandez DP; Beaudette P; Korkmaz B; Dittmar G; Kettritz R
Kidney Int; 2015 Oct; 88(4):764-75. PubMed ID: 26061547
[TBL] [Abstract][Full Text] [Related]
38. Cathepsin C inhibitors as anti-inflammatory drug discovery: Challenges and opportunities.
Shen XB; Chen X; Zhang ZY; Wu FF; Liu XH
Eur J Med Chem; 2021 Dec; 225():113818. PubMed ID: 34492551
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic utility and medicinal chemistry of cathepsin C inhibitors.
Guay D; Beaulieu C; Percival MD
Curr Top Med Chem; 2010; 10(7):708-16. PubMed ID: 20337582
[TBL] [Abstract][Full Text] [Related]
40. Dipeptidyl Peptidase 1 Inhibitor AZD7986 Induces a Sustained, Exposure-Dependent Reduction in Neutrophil Elastase Activity in Healthy Subjects.
Palmér R; Mäenpää J; Jauhiainen A; Larsson B; Mo J; Russell M; Root J; Prothon S; Chialda L; Forte P; Egelrud T; Stenvall K; Gardiner P
Clin Pharmacol Ther; 2018 Dec; 104(6):1155-1164. PubMed ID: 29484635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
